These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10089626)

  • 21. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
    Masterson TA; Pettus JA; Middleton RG; Stephenson RA
    Urology; 2005 Jul; 66(1):152-5. PubMed ID: 15992904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic versus open radical prostatectomy: a comparative study at a single institution.
    Rassweiler J; Seemann O; Schulze M; Teber D; Hatzinger M; Frede T
    J Urol; 2003 May; 169(5):1689-93. PubMed ID: 12686809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
    Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
    J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
    van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
    Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of a series of radical prostatectomies].
    Rioja Sanz LA; Liedana Torres JM; Roncales Badal A; Gil Sanz MJ; Villanueva Benedicto A; Rodríguez Vela L; Gil Martínez P
    Actas Urol Esp; 1997 Oct; 21(9):809-16. PubMed ID: 9471862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases].
    Roche JB; Malavaud B; Soulié M; Cournot M; Gamé X; Mazerolles C; Bachaud JM; Plante P; Rischmann P
    Prog Urol; 2008 Oct; 18(9):586-94. PubMed ID: 18986631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens.
    Kohl SK; Balaji KC; Smith LM; Wilson NP; Johansson SL; Sterrett SP; Abrahams NA
    Urology; 2007 Jun; 69(6):1112-6. PubMed ID: 17572197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    Carini M; Masieri L; Minervini A; Lapini A; Serni S
    Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasion of bladder neck after radical prostatectomy: one definition for different outcomes.
    Rodriguez-Covarrubias F; Larré S; Dahan M; De La Taille A; Allory Y; Yiou R; Vordos D; Hoznek A; Abbou CC; Salomon L
    Prostate Cancer Prostatic Dis; 2008; 11(3):294-7. PubMed ID: 17876340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radical prostatectomy in clinically localized prostatic adenocarcinoma. Factors influencing biochemical progression free survival].
    Zudaire Bergera JJ; Martín-Marquina Aspiunza A; Sánchez Zalabardo D; Arocena García-Tapia J; Sanz Pérez G; Díez Caballero F; Rosell Costa D; Robles García JE; Berián Polo JM
    Actas Urol Esp; 1999 Apr; 23(4):333-41. PubMed ID: 10394654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morbidity of laparoscopic extraperitoneal versus transperitoneal radical prostatectomy verus open retropubic radical prostatectomy.
    Remzi M; Klingler HC; Tinzl MV; Fong YK; Lodde M; Kiss B; Marberger M
    Eur Urol; 2005 Jul; 48(1):83-9; discussion 89. PubMed ID: 15967256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.
    Weight CJ; Reuther AM; Gunn PW; Zippe CR; Dhar NB; Klein EA
    Urology; 2008 Jan; 71(1):141-5. PubMed ID: 18242383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up].
    Isorna Martínez de la Riva S; Belón López-Tomasety J; Marrero Domínguez R; Alvarez Cruz E; Santamaría Blanco P
    Arch Esp Urol; 2004 Sep; 57(7):679-92. PubMed ID: 15536949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
    Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW
    Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
    Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.